Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia

Clinical trial NCT00047190 · COMPLETED

Trial details

NCT number: NCT00047190
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Thrombocythemia Polycythemia Vera Primary Myelofibrosis

Start date: 2002-08-01
Primary completion: 2007-04-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.